The valley of death: why Australia failed to develop clinically effective drugs in COVID-19
Description
There is a paucity of public discussion of costs spent on drug trials during coronavirus disease 2019 (COVID-19) and their value, and of large public outlay on research funding for vaccine and drug development that did not deliver medicines nor